Bevacizumab in Recurrent Grade II and III Glioma
Clinical trial NCT01164189 · COMPLETED
Trial details
- NCT number
- NCT01164189
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2017-01-19
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.